Abstract:Journal of Dental Research, Ahead of Print. The prognosis and survival rate of head and neck squamous cell carcinoma (HNSCC) have remained unchanged for years, and the pathogenesis of HNSCC is still not fully understood, necessitating further research. An ideal animal model that accurately replicates the complex microenvironment of HNSCC is urgently needed. Among all the animal models for preclinical cancer research, tumor-bearing mouse models are the best known and widely used due to their high similarity to humans. Currently, mouse models for HNSCC can be broadly categorized into chemical-induced models, genetically engineered mouse models (GEMMs), and transplanted mouse models, each with its distinct advantages and limitations. In chemical-induced models, the carcinogen spontaneously initiates tumor formation through a multistep process. The resemblance of this model to human carcinogenesis renders it an ideal preclinical platform for studying HNSCC initiation and progression from precancerous lesions. The major drawback is that these models are time-consuming and, like human cancer, unpredictable in terms of timing, location, and number of lesions. GEMMs involve transgenic and knockout mice with gene modifications, leading to malignant transformation within a tumor microenvironment that recapitulates tumorigenesis in vivo, including their interaction with the immune system. However, most HNSCC GEMMs exhibit low tumor incidence and limited prognostic significance when translated to clinical studies. Transplanted mouse models are the most widely used in cancer research due to their consistency, availability, and efficiency. Based on the donor and recipient species matching, transplanted mouse models can be divided into xenografts and syngeneic models. In the latter, transplanted cells and host are from the same strain, making syngeneic models relevant to study functional immune system. In this review, we provide a comprehensive summary of the characteristics, establishment methods, and potential applications of these different HNSCC mouse models, aiming to assist researchers in choosing suitable animal models for their research.

Application of mouse models for drug carcinogenicity testing and the need for development of humanized models

Humanized Rodent Models for Cancer Research

Patient-derived Human Tumour Tissue Xenografts in Immunodeficient Mice: a Systematic Review

Development of human cell models for assessing the carcinogenic potential of chemicals

Genetically humanized mouse models of drug metabolizing enzymes and transporters and their applications

P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity

Experimental mouse models for translational human cancer research

Genetic toxicity assessment using liver cell models: past, present, and future

Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: A comprehensive review

Mouse models for mesothelioma drug discovery and development

Humanized Mouse Models for Immuno-oncology Drug Discovery

Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells

Disease research and drug development models based on genetically altered human embryonic stem cells.

[Application and Recent Advances of Laboratory Mouse in Human Cancer Research].

Mouse Models for Head and Neck Squamous Cell Carcinoma

The design, analysis and application of mouse clinical trials in oncology drug development

Translation Potential and Challenges of In Vitro and Murine Models in Cancer Clinic

Mouse models for pre-clinical drug testing in leukemia

Models of breast cancer: quo vadis, animal modeling?

In Silico Approaches In Carcinogenicity Hazard Assessment: Current Status and Future Needs

Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models